Press coverage about Innospec (NASDAQ:IOSP) has been trending somewhat positive recently, Accern Sentiment reports. The research group ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Innospec earned a media sentiment score of 0.21 on Accern’s scale. Accern also gave media headlines about the specialty chemicals company an impact score of 47.8644181843504 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Here are some of the news stories that may have impacted Accern Sentiment Analysis’s rankings:
- Tieton Capital Management LLC Sells 2,730 Shares of Innospec Inc. (IOSP) (americanbankingnews.com)
- Innospec Inc. (IOSP) VP Sells $94,307.68 in Stock (americanbankingnews.com)
- Champlain Investment Partners LLC Lowers Holdings in Innospec Inc. (IOSP) (americanbankingnews.com)
- Innospec Inc. (IOSP) CFO Sells $154,991.55 in Stock (americanbankingnews.com)
- Innospec Inc. (IOSP) Insider David Earl Williams Sells 3,142 Shares (americanbankingnews.com)
Several analysts have weighed in on the company. Zacks Investment Research raised Innospec from a “hold” rating to a “buy” rating and set a $76.00 price objective for the company in a report on Friday, November 10th. Johnson Rice raised Innospec from a “hold” rating to an “accumulate” rating in a report on Tuesday, November 14th. BidaskClub raised Innospec from a “sell” rating to a “hold” rating in a report on Wednesday, December 27th. ValuEngine raised Innospec from a “hold” rating to a “buy” rating in a report on Thursday, November 9th. Finally, KeyCorp reissued an “overweight” rating on shares of Innospec in a report on Thursday, November 9th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $70.50.
Innospec (NASDAQ:IOSP) last posted its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.47 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.13 by $0.34. The company had revenue of $353.80 million during the quarter. Innospec had a return on equity of 15.57% and a net margin of 4.73%. equities research analysts predict that Innospec will post 4.3 earnings per share for the current fiscal year.
In related news, CFO Ian Cleminson sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $71.67, for a total value of $358,350.00. Following the completion of the transaction, the chief financial officer now directly owns 22,997 shares in the company, valued at approximately $1,648,194.99. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Catherine Hessner sold 1,382 shares of the business’s stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $68.24, for a total value of $94,307.68. Following the completion of the transaction, the vice president now owns 27,518 shares of the company’s stock, valued at $1,877,828.32. The disclosure for this sale can be found here. Insiders have sold a total of 12,286 shares of company stock valued at $856,589 over the last 90 days. Corporate insiders own 2.02% of the company’s stock.
Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.